Document
IPR2019-00451, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Oct. 2, 2019)
Cite Document
IPR2019-00451, No. 3001 Exhibit - Ex 3001 (P.T.A.B. Oct. 2, 2019)
+ More Snippets
Document
IPR2019-00451, No. 1152 Exhibit - DECLARATION OF MICHAEL I CHAKANSKY (P.T.A.B. Apr. 28, 2020)
Cite Document
IPR2019-00451, No. 1152 Exhibit - DECLARATION OF MICHAEL I CHAKANSKY (P.T.A.B. Apr. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 2025 Exhibit - Affidavit of Robert Cleary (P.T.A.B. Apr. 28, 2020)
Cite Document
IPR2019-00451, No. 2025 Exhibit - Affidavit of Robert Cleary (P.T.A.B. Apr. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1108 Exhibit - Smith B Treatment of status epilepticus Neurol Clin 2001 19 347 369 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1108 Exhibit - Smith B Treatment of status epilepticus Neurol Clin 2001 19 347 369 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1116 Exhibit - Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1116 Exhibit - Illum L Is nose to brain transport of drugs a reality JPP 2004 56 3 17 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1148 Exhibit - FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Section 505b2, httpswwwfdagovmedia72419download (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1148 Exhibit - FDA GUIDANCE FOR INDUSTRY 1999, Applications Covered by Section 505b2, httpswwwfdagovmedia72419download (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1120 Exhibit - Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vas...
Cite Document
IPR2019-00451, No. 1120 Exhibit - Davis GA, Rudy AC, Archer SM, Wermeling DP, McNamara PJ, Bioavailability and pharmacokinetics of intranasal hydromorphone in patients experiencing vasomotor rhinitis
+ More Snippets
Document
IPR2019-00451, No. 1147 Exhibit - CDER 2019 09 19 Abbreviated Approval Products505b2 or ANDA httpswwwfdagovdrugscder small business industry assistance sbiaabbreviated approval pa...
Cite Document
IPR2019-00451, No. 1147 Exhibit - CDER 2019 09 19 Abbreviated Approval Products505b2 or ANDA httpswwwfdagovdrugscder small business industry assistance sbiaabbreviated approval pathways drug product 5
+ More Snippets
Document
IPR2019-00451, No. 1143 Exhibit - Jeannet, PY, et al, Home and hospital treatment of acute seizures in children with nasal midazolam Eur J Paediatr Neurol, 1999 32 p 73 7 (P.T.A.B. Jan. 28, 20...
Cite Document
IPR2019-00451, No. 1143 Exhibit - Jeannet, PY, et al, Home and hospital treatment of acute seizures in children with nasal midazolam Eur J Paediatr Neurol, 1999 32 p 73 7 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1077 Exhibit - Ritchel, WA, et al, Handbook of Basic Pharmocokinetics ¿¿¿ Including Clinical Applications, 6th Edition, 2004 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1077 Exhibit - Ritchel, WA, et al, Handbook of Basic Pharmocokinetics ¿¿¿ Including Clinical Applications, 6th Edition, 2004 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 2007 Exhibit - E Bechgaard et al, ¿¿¿Solubilization of Various Benzodiazepines for Intranasal Administration, A Pilot Study,¿¿¿ Pharmaceutical Development and Technology 2...
Cite Document
IPR2019-00451, No. 2007 Exhibit - E Bechgaard et al, ¿¿¿Solubilization of Various Benzodiazepines for Intranasal Administration, A Pilot Study,¿¿¿ Pharmaceutical Development and Technology 2293 296 19
+ More Snippets
Document
IPR2019-00451, No. 1151 Exhibit - Wermeling, DP, Intranasal delivery of antiepileptic medications for treatment of seizures, Neurotherapeutics, April 2009, Volume 6, Issue 2, pp 352¿¿¿358 (P.T...
Cite Document
IPR2019-00451, No. 1151 Exhibit - Wermeling, DP, Intranasal delivery of antiepileptic medications for treatment of seizures, Neurotherapeutics, April 2009, Volume 6, Issue 2, pp 352¿¿¿358 (P.T.A.B.
+ More Snippets
Document
IPR2019-00451, No. 1119 Exhibit - Davis GA, Rudy AC, Archer SA, Wermeling DP, McNamara PJ Effect of fluticasone propionate nasal spray on bioavailability of hydromorphone hydrochloride i...
Cite Document
IPR2019-00451, No. 1119 Exhibit - Davis GA, Rudy AC, Archer SA, Wermeling DP, McNamara PJ Effect of fluticasone propionate nasal spray on bioavailability of hydromorphone hydrochloride in patients wi
+ More Snippets
Document
IPR2019-00451, No. 1103 Exhibit - Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome in posttraumatic seizures J Trauma 2008 64 883 888 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1103 Exhibit - Wang HC, Chang WN, Chang HW, et al Factors predictive of outcome in posttraumatic seizures J Trauma 2008 64 883 888 (P.T.A.B. Jan. 28, 2020)
+ More Snippets
Document
IPR2019-00451, No. 1101 Exhibit - Lowenstein DH, Alldredge BK Status epilepticus N Eng J Med 1998 338 970 976 (P.T.A.B. Jan. 28, 2020)
Cite Document
IPR2019-00451, No. 1101 Exhibit - Lowenstein DH, Alldredge BK Status epilepticus N Eng J Med 1998 338 970 976 (P.T.A.B. Jan. 28, 2020)
+ More Snippets